[1]
S. Proctor and J. Wilkinson, “Current status of anti-CD30 monoclonal antibody therapy in anaplastic lymphoma and Hodgkin’s lymphoma”, Hematol Meeting Rep, vol. 2, no. 13, Jun. 2009.